Zieve syndrome
Zieve syndrome is also known as alcoholic hyperlipidemia syndrome, icteric transient hyperlipidemia-hemolytic anemia syndrome, and alcoholism hyperlipidemia-hemolytic syndrome. It was first reported by Zieve in 1958 and named Zieve syndrome by Balcerzak in 1968. It refers to a group of diseases in which chronic alcoholism patients have jaundice, hyperlipidemia, and hemolytic anemia.
-
Site of disease:
Blood vessels skin whole body -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Liver enlargement poor appetite ascites cirrhosis dyslipidemia -
Concurrent disease:
Related Drugs
Clofibrate Capsules
Indication: Hyperlipidemia, its triglyceride-lowering effect is more obvious than its cholesterol-lowering effect. In view of the potential carcinogenicity of this product to humans, its use should be strictly limited to the specified range of indications, and the drug should be discontinued in time if the therapeutic effect is not obvious.
Meclofenoxate Hydrochloride for Injection
Indication: Suitable for traumatic coma, alcohol poisoning, neonatal hypoxia, and enuresis in children.
Simvastatin Capsules
Indication: Used for the treatment of hypercholesterolemia and combined hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Manufacturer:
Shandong Lukang Pharmaceutical Co., Ltd.
Vitamin K1 Injection
Indication: It is used for bleeding caused by vitamin K deficiency, such as bleeding caused by obstructive jaundice, bile fistula, chronic diarrhea, etc., and low<Aclass=bluehref=http://ypk.
Manufacturer:
Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.
Bezafibrate Tablets
Indication: It is suitable for hyperlipidemia caused by various reasons, and is effective in lowering cholesterol and triglycerides. It can be used for both familial and non-familial hyperlipidemia. It can be used as a first-line lipid-lowering drug, and as an alternative drug when other lipid-lowering drugs fail. It is especially suitable for patients with hyperlipidemia and diabetes, because it can not only lower blood lipids but also improve glucose tolerance. While lowering lipids, the drug can significantly reduce the risk of atherosclerosis in patients.
Manufacturer:
Kun Shan Rotam Reddy Pharmaceutical Co., Ltd.
Zhibituo Tablets
Manufacturer:
Chengdu DIAO Jiuhong Pharmaceutical Factory
Probucol tablets
Indication: Used to treat hypercholesterolemia.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Mannolate tablets
Indication: Used to treat hyperlipidemia.
Manufacturer:
Qingdao Guoxin Pharmaceutical Co., Ltd.
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.